Related Experiment Video
Updated: Jul 6, 2026
08:35
Generation of a Three-dimensional Full Thickness Skin Equivalent and Automated Wounding
Published on: February 26, 2015
[Experimental study on repairing full-thickness cutaneous deficiency with tissue engineered skin]
Cong Zhang1, Naizuo Wang, Hui Chen
1Department of Burns, Beijing Jishuitan Hospital, 100035, P.R. China.
Summary
Tissue engineered skin substitutes using human epidermal stem cells and fibroblasts in a fibrin frame show promise for repairing skin defects. This innovative approach accelerates wound healing and reduces scarring compared to traditional methods.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Tissue Engineering
Background:
- Full-thickness cutaneous defects pose significant challenges in wound healing and regeneration.
- Current treatments often result in scarring and incomplete functional recovery.
- Tissue-engineered skin substitutes offer a potential solution for improved skin repair.
Purpose of the Study:
- To evaluate the feasibility of a novel tissue-engineered skin substitute (TES) for repairing full-thickness skin defects.
- To assess the efficacy of TES composed of human epidermal stem cells and fibroblasts within a fibrin scaffold.
- To compare the healing outcomes of the TES against various control groups in a murine model.
Main Methods:
- Human epidermal stem cells and fibroblasts were cultured and combined within a fibrin scaffold to create the TES.
- The TES was grafted onto full-thickness cutaneous defects in nude mice, divided into experimental and control groups.
- Histology, immunohistochemistry, and scanning electron microscopy were employed to analyze wound healing at multiple time points post-surgery.
Main Results:
- The TES group demonstrated significantly faster wound healing and reduced scarring compared to control groups.
- Histological and SEM analyses revealed enhanced vascularization and more organized collagen fiber alignment in the TES group.
- Immunohistochemistry confirmed the presence of specific markers (Collagen IV, CK14) indicating successful skin regeneration in the TES group.
Conclusions:
- The developed tissue-engineered skin substitute, incorporating human epidermal stem cells and fibroblasts in a fibrin frame, shows significant potential for clinical application.
- This TES promotes faster wound healing and superior tissue regeneration in full-thickness cutaneous defects.
- Further research is warranted to explore the full therapeutic potential of this biomaterial-based regenerative approach.
